Robert O’Connor

8.7k total citations
123 papers, 3.6k citations indexed

About

Robert O’Connor is a scholar working on Oncology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert O’Connor has authored 123 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 36 papers in Molecular Biology and 19 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert O’Connor's work include Drug Transport and Resistance Mechanisms (15 papers), HER2/EGFR in Cancer Research (11 papers) and Cardiac Arrest and Resuscitation (11 papers). Robert O’Connor is often cited by papers focused on Drug Transport and Resistance Mechanisms (15 papers), HER2/EGFR in Cancer Research (11 papers) and Cardiac Arrest and Resuscitation (11 papers). Robert O’Connor collaborates with scholars based in Ireland, United States and United Kingdom. Robert O’Connor's co-authors include Martin Clynes, Robert S. Zeiger, Alan B. Forsythe, Robert N. Hamburger, Susan Heller, Michael Mellon, Michael Schätz, Lorraine O’Driscoll, Kevin Kavanagh and Mary Heenan and has published in prestigious journals such as Angewandte Chemie International Edition, Circulation and Journal of Clinical Oncology.

In The Last Decade

Robert O’Connor

117 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert O’Connor Ireland 35 1.2k 898 445 385 338 123 3.6k
Robert Wolf United States 45 1.2k 1.0× 906 1.0× 122 0.3× 1.7k 4.3× 290 0.9× 178 6.9k
Michael D. Wiese Australia 37 752 0.6× 1.0k 1.2× 61 0.1× 368 1.0× 272 0.8× 200 5.2k
James W. Dear United Kingdom 39 2.8k 2.4× 344 0.4× 540 1.2× 398 1.0× 1.4k 4.0× 158 6.3k
Victor R. Gordeuk United States 57 1.8k 1.5× 399 0.4× 148 0.3× 341 0.9× 802 2.4× 401 11.8k
Jonathan Kay United States 47 866 0.7× 532 0.6× 69 0.2× 607 1.6× 179 0.5× 224 7.6k
Ping Fu China 33 1.4k 1.2× 366 0.4× 114 0.3× 820 2.1× 294 0.9× 178 4.9k
Jean‐Michel Dogné Belgium 41 1.4k 1.2× 275 0.3× 110 0.2× 476 1.2× 282 0.8× 212 6.0k
Helen K. Chew United States 34 1.0k 0.9× 1.4k 1.6× 78 0.2× 590 1.5× 576 1.7× 89 5.4k
Richard J. Bold United States 43 1.8k 1.6× 2.5k 2.8× 127 0.3× 1.6k 4.0× 1.0k 3.1× 205 6.1k
Bruno Morgan United Kingdom 32 1.2k 1.1× 620 0.7× 221 0.5× 349 0.9× 285 0.8× 117 4.3k

Countries citing papers authored by Robert O’Connor

Since Specialization
Citations

This map shows the geographic impact of Robert O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert O’Connor more than expected).

Fields of papers citing papers by Robert O’Connor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert O’Connor. The network helps show where Robert O’Connor may publish in the future.

Co-authorship network of co-authors of Robert O’Connor

This figure shows the co-authorship network connecting the top 25 collaborators of Robert O’Connor. A scholar is included among the top collaborators of Robert O’Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert O’Connor. Robert O’Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bernier, Emily, Daniel C. Kopala‐Sibley, Sabine Soltani, et al.. (2024). Pain and Post-traumatic Stress Disorder Symptoms: Dyadic Relationships Between Canadian Armed Forces Members/Veterans With Chronic Pain and Their Offspring. Journal of Pain. 25(8). 104516–104516. 1 indexed citations
2.
Gallagher, William M., Rustom P. Manecksha, David Galvin, et al.. (2024). IMPROVER (Involving Men with Prostate Cancer in Engaged Research): Assessing Patient Experience With Testing, Diagnosis, And Surveillance. Clinical Genitourinary Cancer. 22(3). 102063–102063. 1 indexed citations
3.
4.
Grimes, David Robert, et al.. (2020). Establishing a taxonomy of potential hazards associated with communicating medical science in the age of disinformation. BMJ Open. 10(7). e035626–e035626. 11 indexed citations
5.
Gaule, Patricia, Nupur Mukherjee, B. Corkery, et al.. (2019). Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells. Cancers. 11(4). 548–548. 19 indexed citations
6.
Yin, Qian, et al.. (2017). A non-contrast CMR index for assessing myocardial fibrosis. Magnetic Resonance Imaging. 42. 69–73. 21 indexed citations
7.
Yan, Guofen, et al.. (2016). Mass gathering medicine: event factors predicting patient presentation rates. Internal and Emergency Medicine. 11(5). 745–752. 26 indexed citations
8.
O’Connor, Robert, S. Rand, Lizzie Grillo, et al.. (2015). WS21.6 Prognostic value of breathing reserve index at anaerobic threshold during cardiopulmonary exercise testing in children with cystic fibrosis. Journal of Cystic Fibrosis. 14. S40–S40.
9.
Madden, Stephen F., Martin Clynes, John Crown, et al.. (2013). A gene expression profile indicative of early stage HER2 targeted therapy response. Molecular Cancer. 12(1). 69–69. 21 indexed citations
10.
Ninjbadgar, Tsedev, Sandra Roche, Robert O’Connor, et al.. (2013). Stable Aqueous Dispersions of Glycopeptide‐Grafted Selectably Functionalized Magnetic Nanoparticles. Angewandte Chemie International Edition. 52(11). 3164–3167. 74 indexed citations
11.
Rajpal, Rajesh K., Paul Dowling, Justine Meiller, et al.. (2011). A novel panel of protein biomarkers for predicting response to thalidomide‐based therapy in newly diagnosed multiple myeloma patients. PROTEOMICS - CLINICAL APPLICATIONS. 5(9-10). 551–551. 3 indexed citations
12.
McCommis, Kyle S., et al.. (2011). T2 preparation method for measuring hyperemic myocardial O2 consumption: in vivo validation by positron emission tomography. Journal of Magnetic Resonance Imaging. 33(2). 320–327.
13.
Martínez, Vanesa G., Kaye J. Williams, Ian J. Stratford, Martin Clynes, & Robert O’Connor. (2008). Overexpression of cytochrome P450 NADPH reductase sensitises MDA 231 breast carcinoma cells to 5-fluorouracil: Possible mechanisms involved. Toxicology in Vitro. 22(3). 582–588. 22 indexed citations
14.
15.
O’Connor, Robert. (2003). Plan early, retire happy.. PubMed. 17(16). 16–7. 2 indexed citations
16.
Morán, E, et al.. (2002). Methods for generation of monoclonal antibodies to the very small drug hapten, 5-benzimidazolecarboxylic acid. Journal of Immunological Methods. 271(1-2). 65–75. 13 indexed citations
17.
O’Connor, Robert, John O’Sullivan, & Richard O’Kennedy. (1996). Determination of serum and tissue levels of phenazines including clofazimine. Journal of Chromatography B Biomedical Sciences and Applications. 681(2). 307–315. 16 indexed citations
18.
O’Connor, Robert & Philip F. Kelly. (1980). A Study of Industrial Workers' Co-Operatives. Trinity's Access to Research Output (TARA) (Trinity College Dublin). 3 indexed citations
19.
Hopkins, Raymond F., Richard W. Mansbach, Robert S. Erikson, et al.. (1972). PSR volume 66 issue 4 Cover and Front matter. American Political Science Review. 66(4). f1–f9. 1 indexed citations
20.
O’Connor, Robert, et al.. (1966). The effects of severe hypoxia on the canine electrocardiogram with particular reference to the QRS complex. Journal of Surgical Research. 6(3). 99–106. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Wolf Breakdown of academic impact, for papers by Michael D. Wiese Breakdown of academic impact, for papers by James W. Dear Breakdown of academic impact, for papers by Victor R. Gordeuk Breakdown of academic impact, for papers by Jonathan Kay Breakdown of academic impact, for papers by Ping Fu Breakdown of academic impact, for papers by Jean‐Michel Dogné Breakdown of academic impact, for papers by Helen K. Chew Breakdown of academic impact, for papers by Richard J. Bold Breakdown of academic impact, for papers by Bruno Morgan
Rankless by CCL
2026